Hepatitis
PEG-INTRON is now available in Japan for hepatitis C treatment
Published in Drug Week, January 14th, 2005
PEG-INTRON and REBETOL are marketed worldwide by Schering-Plough Corporation (NYSE: SGP).
PEG-INTRON and REBETOL combination therapy is the first and only pegylated interferon-based combination therapy approved in Japan. An estimated 1 to 2 million Japanese are chronically infected with hepatitis C. PEG-INTRON is a longer-acting form of INTRON A (interferon alfa-2b, recombinant) Injection that uses proprietary PEG technology developed by Enzon. Under the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2005-01-14)
More Articles from Drug Week
- Chronic Lymphocytic Leukemia
Combination of MabCampath and Fludara shown to be highly effective in CLL - Insulin Delivery
Successful results reported from phase II intranasal insulin study - Multiple Myeloma
Pivotal phase III trial for stem cell transplant drug to be initiated - Non-Hodgkin Lymphoma
Ganite activity in patients with advanced NHL presented at ASH meeting - Abciximab
Immunologic origin of abciximab-induced thrombocytopenia determined - Acute Leukemia Therapy
FLAD regimen shows promise for high-risk patients - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
